question
stringlengths
47
751
answer
stringlengths
4
183
slide_id
stringlengths
23
23
project
stringclasses
1 value
f1024
stringlengths
139
139
f2048
stringlengths
138
138
f4096
stringlengths
139
139
what additional finding was observed at the edges of the tumor? A. fibroadenoma B. carcinoma in situ (cis) C. invasive lobular carcinoma D. ductal carcinoma in situ (dcis)
B. carcinoma in situ (cis)
TCGA-D8-A1JJ-01Z-00-DX2
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_1_1024.npy
what is the histopathological diagnosis of the breast tumor? A. invasive ductal carcinoma B. invasive lobular carcinoma C. inflammatory breast carcinoma D. phyllodes tumor
A. invasive ductal carcinoma
TCGA-D8-A1JJ-01Z-00-DX2
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_1_1024.npy
what was the result of her2 protein staining in the invasive cancerous cells? A. positive B. negative C. uncertain D. not mentioned
B. negative
TCGA-D8-A1JJ-01Z-00-DX2
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_1_1024.npy
what type of breast cancer did the patient have? A. infiltrating lobular carcinoma B. ductal carcinoma in situ C. invasive ductal carcinoma D. metastatic breast cancer
A. infiltrating lobular carcinoma
TCGA-AR-A5QP-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_1_1024.npy
what is the tumor grade of the cancer? A. nottingham grade i B. nottingham grade ii C. nottingham grade iii D. nottingham grade iv
A. nottingham grade i
TCGA-AR-A5QP-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_1_1024.npy
did the tumor invade blood or lymphatic vessels? A. yes B. no C. insufficient information D. not applicable
B. no
TCGA-AR-A5QP-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_1_1024.npy
what type of changes were observed in the non-cancerous tissue? A. proliferative fibrocystic changes B. ductal carcinoma in situ changes C. hyperplastic changes D. nonproliferative fibrocystic changes
D. nonproliferative fibrocystic changes
TCGA-AR-A5QP-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_1_1024.npy
what is the staging of the cancer according to the ajcc system? A. t1n0(sn) B. t1n1(sn) C. t2n0(sn) D. t2n1(sn)
D. t2n1(sn)
TCGA-AR-A5QP-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QP-01Z-00-DX1.256FDB13-1F81-42DA-AF6E-8A94835550C1_1_1024.npy
what is the nottingham grade of the invasive ductal carcinoma? A. grade 1 B. grade 2 C. grade 3 D. grade 4
C. grade 3
TCGA-BH-A0RX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_1_1024.npy
what are the findings in the breast associated with the invasive ductal carcinoma? A. microcalcifications only B. lymphoplasmacytic infiltrate only C. comedonecrosis only D. microcalcifications, lymphoplasmacytic infiltrate, and comedonecrosis
D. microcalcifications, lymphoplasmacytic infiltrate, and comedonecrosis
TCGA-BH-A0RX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_1_1024.npy
was lymphovascular invasion identified in the breast? A. yes B. no C. insufficient information D. not applicable
B. no
TCGA-BH-A0RX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_1_1024.npy
what were the additional findings in the breast? A. fibroadenomata and stromal fibrosis B. fibrocystic changes C. adenosis and fat necrosis D. papillomas and lobular hyperplasia
A. fibroadenomata and stromal fibrosis
TCGA-BH-A0RX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3_1_1024.npy
what is the histopathologic type of the breast cancer? A. ducal B. lobular C. inflammatory D. metastatic
B. lobular
TCGA-XX-A899-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_1_1024.npy
what is the grade of the tumor according to the nottingham grading system? A. grade 1 B. grade 2 C. grade 3 D. grade 4
B. grade 2
TCGA-XX-A899-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_1_1024.npy
what is the stage of the tumor according to the tnm classification system? A. pt1a B. pt1b C. pt1c D. pt1d
C. pt1c
TCGA-XX-A899-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_1_1024.npy
what is the hormone receptor status of the breast cancer? A. positive for estrogen and progesterone receptors B. negative for estrogen and progesterone receptor C. positive for her-2/neu D. negative for her-2/neu
A. positive for estrogen and progesterone receptors
TCGA-XX-A899-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_1_1024.npy
is there any distant metastasis detected in the breast cancer? A. yes B. no C. not sure D. cannot tell
B. no
TCGA-XX-A899-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-XX-A899-01Z-00-DX1.08FE27B7-73B8-4CE3-ACF4-0689C81C140B_1_1024.npy
what is the diagnosis for the patient's breast? A. invasive ductal carcinoma grade 1 B. invasive ductal carcinoma grade 3 C. invasive lobular carcinoma grade 3 D. ductal carcinoma in situ (dcis) with low nuclear grade
B. invasive ductal carcinoma grade 3
TCGA-AC-A8OQ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A8OQ-01Z-00-DX1.15946A44-711C-4765-AB46-5CFB7BD11E42_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A8OQ-01Z-00-DX1.15946A44-711C-4765-AB46-5CFB7BD11E42_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A8OQ-01Z-00-DX1.15946A44-711C-4765-AB46-5CFB7BD11E42_1_1024.npy
what was found in the lumpectomy margins? A. tumor cells present in all margins B. margins are free of tumor C. tumor cells present in the deep margin D. tumor cells present in the lateral margin
B. margins are free of tumor
TCGA-AC-A8OQ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A8OQ-01Z-00-DX1.15946A44-711C-4765-AB46-5CFB7BD11E42_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A8OQ-01Z-00-DX1.15946A44-711C-4765-AB46-5CFB7BD11E42_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A8OQ-01Z-00-DX1.15946A44-711C-4765-AB46-5CFB7BD11E42_1_1024.npy
what is the nottingham grade of the ductal carcinoma? A. grade i B. grade ii C. grade iii D. grade iv
B. grade ii
TCGA-AR-A252-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A252-01Z-00-DX1.2E7EE069-A0B8-489B-A2F0-3175FB58F468_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A252-01Z-00-DX1.2E7EE069-A0B8-489B-A2F0-3175FB58F468_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A252-01Z-00-DX1.2E7EE069-A0B8-489B-A2F0-3175FB58F468_1_1024.npy
what is the tumor stage according to the ajcc staging system? A. pt1a B. pt1b C. pt1c D. pt1d
C. pt1c
TCGA-AR-A252-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A252-01Z-00-DX1.2E7EE069-A0B8-489B-A2F0-3175FB58F468_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A252-01Z-00-DX1.2E7EE069-A0B8-489B-A2F0-3175FB58F468_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A252-01Z-00-DX1.2E7EE069-A0B8-489B-A2F0-3175FB58F468_1_1024.npy
what type of tumor is present? A. squamous cell carcinoma B. invasive ductal carcinoma C. leiomyosarcoma D. fibroadenoma
B. invasive ductal carcinoma
TCGA-A2-A0CS-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CS-01Z-00-DX1.3986B545-63E8-4727-BCC1-701DE947D1FB_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CS-01Z-00-DX1.3986B545-63E8-4727-BCC1-701DE947D1FB_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CS-01Z-00-DX1.3986B545-63E8-4727-BCC1-701DE947D1FB_1_1024.npy
what is the ajcc classification of the tumor? A. pt4b(ulceration)n2amx B. pt3(dermal invasion)n1am0 C. pt2n2am0 D. pt4(ulceration)n1amx
A. pt4b(ulceration)n2amx
TCGA-A2-A0CS-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CS-01Z-00-DX1.3986B545-63E8-4727-BCC1-701DE947D1FB_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CS-01Z-00-DX1.3986B545-63E8-4727-BCC1-701DE947D1FB_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CS-01Z-00-DX1.3986B545-63E8-4727-BCC1-701DE947D1FB_1_1024.npy
what type of invasion is present in the tumor? A. lymph vascular invasion B. perineural invasion C. both a and b D. neither a nor b
C. both a and b
TCGA-A2-A0CS-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CS-01Z-00-DX1.3986B545-63E8-4727-BCC1-701DE947D1FB_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CS-01Z-00-DX1.3986B545-63E8-4727-BCC1-701DE947D1FB_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CS-01Z-00-DX1.3986B545-63E8-4727-BCC1-701DE947D1FB_1_1024.npy
what is the classification of the tumor based on microscopic evaluation? A. invasive ductal carcinoma with minimal tubule formation and marked nuclear pleomorphism. B. invasive lobular carcinoma with prominent tubule formation and low nuclear grade. C. ductal carcinoma in situ with minimal tubule formation and marked nuclear pleomorphism. D. lobular carcinoma in situ with prominent tubule formation and low nuclear grade.
A. invasive ductal carcinoma with minimal tubule formation and marked nuclear pleomorphism.
TCGA-EW-A1P4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_1_1024.npy
what is the nottingham score for the tumor? A. grade i tumor. B. grade ii tumor. C. grade iii tumor. D. grade iv tumor.
B. grade ii tumor.
TCGA-EW-A1P4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_1_1024.npy
what is the size classification of the primary tumor? A. pt1a B. pt2b C. pt3c D. pt4a
C. pt3c
TCGA-EW-A1P4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_1_1024.npy
what are the results of the hormone receptor and her 2 testing? A. positive for er, pr, and her 2. B. negative for er, pr, and her 2. C. positive for er and pr, negative for her 2. D. negative for er and pr, positive for her 2.
B. negative for er, pr, and her 2.
TCGA-EW-A1P4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P4-01Z-00-DX1.3E9AE553-83D4-4B09-AB7F-D096BCE3BC4D_1_1024.npy
what type of carcinoma was diagnosed? A. infiltrating lobular carcinoma B. infiltrating ductal carcinoma C. infiltrating papillary carcinoma D. infiltrating mucinous carcinoma
B. infiltrating ductal carcinoma
TCGA-E9-A1R6-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_1_1024.npy
what was the grade of the carcinoma? A. grade 1 B. grade 2 C. grade 3 D. grade 4
B. grade 2
TCGA-E9-A1R6-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_1_1024.npy
did the tumor involve venous invasion? A. yes B. no C. not mentioned D. cannot be determined
B. no
TCGA-E9-A1R6-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_1_1024.npy
what was the laterality of the tumor? A. left side in the upper outer quadrant B. right side in the upper outer quadrant C. left side in the lower outer quadrant D. right side in the lower outer quadrant
B. right side in the upper outer quadrant
TCGA-E9-A1R6-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE_1_1024.npy
what is the final diagnosis of the patient? A. invasive ductal carcinoma, poorly differentiated, with a nottingham score of 6/9 B. infiltrating ductal carcinoma, moderately differentiated, with a nottingham score of 6/9 C. invasive ductal carcinoma, moderately differentiated, with a nottingham score of 8/9 D. ductal carcinoma in situ, with no nottingham score.
B. infiltrating ductal carcinoma, moderately differentiated, with a nottingham score of 6/9
TCGA-A2-A0EY-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_1_1024.npy
are the margins involved? A. yes B. no C. cannot tell D. margin status not mentioned.
B. no
TCGA-A2-A0EY-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_1_1024.npy
is there any necrosis or venous/lymphatic invasion? A. yes B. no C. cannot tell D. mentioned but not clear.
B. no
TCGA-A2-A0EY-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_1_1024.npy
what is the status of her2? A. positive B. negative C. her2 status not mentione D. d: cannot tell.
A. positive
TCGA-A2-A0EY-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_1_1024.npy
are there any other significant pathologic changes? A. no B. usual ductal hyperplasia, fibrocystic changes, and sclerosing adenosis. C. benign fibroadipose tissue and benign breast tissue. D. metastatic carcinoma.
B. usual ductal hyperplasia, fibrocystic changes, and sclerosing adenosis.
TCGA-A2-A0EY-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16_1_1024.npy
what type of breast cancer does the patient have? A. invasive lobular carcinoma B. invasive duct carcinoma C. non-invasive carcinoma D. metastatic carcinoma
B. invasive duct carcinoma
TCGA-A2-A3XZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_1_1024.npy
how many foci of tumor are present in the patient's breast? A. two B. three C. four D. five
C. four
TCGA-A2-A3XZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_1_1024.npy
did the tumor show high differentiation? A. yes B. no C. cannot be determined D. not mentioned in the slide
A. yes
TCGA-A2-A3XZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_1_1024.npy
what surgery did the patient undergo? A. breast reconstruction surgery B. simple mastectomy C. modified radical mastectomy D. partial mastectomy
B. simple mastectomy
TCGA-A2-A3XZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C_1_1024.npy
what type of breast cancer was diagnosed in the patient? A. mucinous breast cancer B. invasive lobular carcinoma C. invasive ductal carcinoma D. medullary breast cancer
C. invasive ductal carcinoma
TCGA-A2-A0T1-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_1_1024.npy
what is the histologic score of the patient? A. 5 B. 7 C. 9 D. 11
C. 9
TCGA-A2-A0T1-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_1_1024.npy
which surgical margin is positive for tumor? A. inferior surgical margin B. medial surgical margin C. superior surgical margin D. lateral surgical margin
C. superior surgical margin
TCGA-A2-A0T1-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_1_1024.npy
what is the pathological tnm stage of the breast cancer? A. 2 n3 mx B. 4 n2 mx C. 3 n3 mx D. 2 n2 mx
C. 3 n3 mx
TCGA-A2-A0T1-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851_1_1024.npy
what were the results of the resection margins? A. positive for carcinoma B. negative for carcinoma C. positive for benign epithelial calcifications D. positive for hormonal receptor
B. negative for carcinoma
TCGA-BH-A0HY-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8_1_1024.npy
what was the hormone receptor status of the invasive tumor cells? A. estrogen receptor positive B. progesterone receptor positive C. her-2 receptor positive D. none of the above
A. estrogen receptor positive
TCGA-BH-A0HY-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8_1_1024.npy
what was the her-2 receptor score? A. 1+ B. 2+ C. 3+ D. 0+
C. 3+
TCGA-BH-A0HY-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8_1_1024.npy
what type of tumor is discussed in this slide? A. prostate tumor B. lung tumor C. breast tumor D. liver tumor
C. breast tumor
TCGA-C8-A12Z-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_1024.npy
what histological pattern is observed in the tumor? A. acinous pattern B. tubular pattern C. diffuse pattern D. papillary pattern
C. diffuse pattern
TCGA-C8-A12Z-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_1024.npy
which molecular markers showed negative results in this slide? A. estrogen receptor (er) and progesterone receptor (pr) B. her-2/neu and b-cell marker C. t-cell marker and pr D. er and her-2/neu
B. her-2/neu and b-cell marker
TCGA-C8-A12Z-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_1024.npy
what is suggested in the slide regarding cellular differentiation and nuclear grade? A. no additional investigation required B. further investigation needed C. high-grade tumor confirmed D. low-grade tumor confirmed
B. further investigation needed
TCGA-C8-A12Z-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_1024.npy
who is the principal investigator mentioned in the slide? A. dr. smith B. dr. johnson C. no principal investigator mentioned D. dr. williams
C. no principal investigator mentioned
TCGA-C8-A12Z-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_1024.npy
what is the comment section in the slide? A. left blank B. contains additional findings C. mentions treatment plan D. provides patient history
A. left blank
TCGA-C8-A12Z-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6_1_1024.npy
what is the chief complaint of patient jeb-0-3? A. back pain B. chest pain C. stomach pain D. headache
B. chest pain
TCGA-C8-A1HI-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_1_1024.npy
what is the patient's birth control method? A. condoms B. oral contraception C. iud D. not specified
D. not specified
TCGA-C8-A1HI-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_1_1024.npy
is the patient positive or negative for hepatitis b and c? A. positive for both b and c B. positive for b, negative for c C. negative for both b and c D. negative for b, positive for c
C. negative for both b and c
TCGA-C8-A1HI-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_1_1024.npy
what diagnostic studies were conducted on the patient? A. x-ray, ultrasound, ct B. ct, mri, pet scan C. ultrasound, ct, mri D. x-ray, pet scan, mri
C. ultrasound, ct, mri
TCGA-C8-A1HI-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_1_1024.npy
what is the purpose of the specimen collected from jeb-0-3? A. treatment B. diagnosis C. research D. testing
C. research
TCGA-C8-A1HI-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8_1_1024.npy
what is the type of cancer diagnosed in the patient? A. adenocarcinoma B. squamous cell carcinoma C. lobular carcinoma D. ductal carcinoma
C. lobular carcinoma
TCGA-A8-A09V-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_1_1024.npy
what is the grade of the tumor? A. g i B. g ii C. g iii D. g iv
B. g ii
TCGA-A8-A09V-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_1_1024.npy
are there any smaller satellite foci observed? A. yes B. no C. not mentioned D. irrelevant
A. yes
TCGA-A8-A09V-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_1_1024.npy
is there any evidence of in situ spread? A. yes B. no C. not mentioned D. irrelevant
A. yes
TCGA-A8-A09V-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_1_1024.npy
what is the stage of the tumor? A. pt1no(0/3;sn)lovoro B. pt2no(0/3;sn)lovoro C. pt3no(0/3;sn)lovoro D. pt4no(0/3;sn)lovoro
B. pt2no(0/3;sn)lovoro
TCGA-A8-A09V-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A09V-01Z-00-DX1.2D6731CA-5712-4EB8-8602-E53301BF4238_1_1024.npy
what was the patient's chief complaint? A. abnormal lymph nodes and thyroid B. unclear C. smoking, alcohol, and drug use D. hepatitis b and c test results
B. unclear
TCGA-C8-A12N-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_1024.npy
what diagnostic studies were performed? A. ultrasound and biopsy B. hepatitis b and c tests C. abnormal lymph nodes and thyroid D. smoking, alcohol, and drug use
A. ultrasound and biopsy
TCGA-C8-A12N-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_1024.npy
what is mentioned in the pathology slide? A. the size and extension of the primary tumor and the presence of metastasis in lymph nodes B. the patient's past medical history C. the appearance of the tumor under the microscope and the presence of certain markers D. the clinical diagnosis
A. the size and extension of the primary tumor and the presence of metastasis in lymph nodes
TCGA-C8-A12N-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_1024.npy
what is not provided in the caption? A. the patient's chief complaint B. the patient's past medical history C. the results of hepatitis b and c tests D. the histological diagnosis and comments
D. the histological diagnosis and comments
TCGA-C8-A12N-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_1024.npy
who signed the pathology slide? A. the principal investigator B. the patient C. the patient's past medical history D. the clinical diagnosis
A. the principal investigator
TCGA-C8-A12N-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_1024.npy
what is not mentioned in the caption? A. the patient's chief complaint B. the patient's past medical history C. the clinical diagnosis D. the pathological staging
D. the pathological staging
TCGA-C8-A12N-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E_1_1024.npy
what type of cancer was present in the breast? A. invasive ductal carcinoma B. benign tumor C. ductal carcinoma in situ D. metastatic carcinoma
A. invasive ductal carcinoma
TCGA-EW-A1IZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_1_1024.npy
what was the histologic grade of the invasive carcinoma? A. grade 3 B. grade 1 C. grade 2 D. grade 4
A. grade 3
TCGA-EW-A1IZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_1_1024.npy
where was lymphovascular invasion observed? A. not mentioned B. only in the tumor C. in the adipose tissue D. not specified
A. not mentioned
TCGA-EW-A1IZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_1_1024.npy
was the tumor hormone receptor positive? A. not mentioned B. yes C. no D. doesn't specify
A. not mentioned
TCGA-EW-A1IZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2_1_1024.npy
what is the final diagnosis for the breast? A. infiltrating lobular carcinoma, nottingham grade il B. infiltrating ductal carcinoma, nottingham grade ii C. lobular carcinoma in situ D. fibrocystic changes
A. infiltrating lobular carcinoma, nottingham grade il
TCGA-AR-A2LN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A2LN-01Z-00-DX1.3EF43524-28B8-4326-9356-6BCBC63A1DA8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A2LN-01Z-00-DX1.3EF43524-28B8-4326-9356-6BCBC63A1DA8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A2LN-01Z-00-DX1.3EF43524-28B8-4326-9356-6BCBC63A1DA8_1_1024.npy
is there angiolymphatic invasion in the breast? A. yes B. no C. not mentioned D. unclear
B. no
TCGA-AR-A2LN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A2LN-01Z-00-DX1.3EF43524-28B8-4326-9356-6BCBC63A1DA8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A2LN-01Z-00-DX1.3EF43524-28B8-4326-9356-6BCBC63A1DA8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A2LN-01Z-00-DX1.3EF43524-28B8-4326-9356-6BCBC63A1DA8_1_1024.npy
what is the classification of the tumor? A. invasive ductal carcinoma B. atypical ductal hyperplasia C. invasive carcinoma D. ductal adenocarcinoma
D. ductal adenocarcinoma
TCGA-BH-A18F-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_1_1024.npy
what hormone receptors are negative in the tumor cells? A. estrogen and progesterone receptors B. her-2/neu receptors C. angiolymphatic receptors D. dermal lymphatic receptors
A. estrogen and progesterone receptors
TCGA-BH-A18F-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_1_1024.npy
what is the nottingham score for the tumor? A. 1 B. 5 C. 9 D. 10
C. 9
TCGA-BH-A18F-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_1_1024.npy
is there evidence of lymphatic invasion? A. yes B. no C. cannot be determined D. inconclusive
B. no
TCGA-BH-A18F-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D_1_1024.npy
what was the specific type of breast carcinoma identified in the mass? A. invasive ductal carcinoma B. ductal carcinoma in situ C. inflammatory breast carcinoma D. mucinous carcinoma
A. invasive ductal carcinoma
TCGA-AR-A24L-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_1_1024.npy
what was the nottingham grade of the invasive ductal carcinoma? A. grade 1 B. grade 2 C. grade 3 D. grade 4
B. grade 2
TCGA-AR-A24L-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_1_1024.npy
was necrosis observed in the ductal carcinoma in situ? A. yes B. no C. no definite
B. no
TCGA-AR-A24L-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_1_1024.npy
what type of ductal carcinoma in situ was identified? A. solid type B. cribriform type C. papillary type D. micropapillary type
A. solid type
TCGA-AR-A24L-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_1_1024.npy
was angiovascular invasion present in the mass? A. yes B. no C. no definite
A. yes
TCGA-AR-A24L-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D_1_1024.npy
what was the type of mass found in the upper mid-quadrant of the breast? A. stellate mass B. hemorrhagic mass C. nodule D. metastatic mass
B. hemorrhagic mass
TCGA-E2-A158-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338_1_1024.npy
in which breast was the mass found in the lower inner quadrant? A. left breast B. right breast C. both breasts D. none of the above
B. right breast
TCGA-E2-A158-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338_1_1024.npy
what samples were submitted for further analysis? A. lymph nodes B. breast tissue C. stellate mass D. hemorrhagic mass
C. stellate mass
TCGA-E2-A158-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338_1_1024.npy
what type of carcinoma is present in the breast? A. invasive lobular carcinoma B. invasive ductal carcinoma C. ductal carcinoma in situ D. benign carcinoma
B. invasive ductal carcinoma
TCGA-EW-A1J5-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2_1_1024.npy
was lymphovascular invasion observed in the breast specimen? A. yes B. no C. not mentioned D. inconclusive
B. no
TCGA-EW-A1J5-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2_1_1024.npy
what is the pathologic staging of the tumor? A. pt1a no mx B. pt1b no mx C. pt1c no mx D. pt2 no mx
C. pt1c no mx
TCGA-EW-A1J5-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J5-01Z-00-DX1.FFE303B1-7F36-4276-B931-C2A6B2CBD1F2_1_1024.npy
what characteristics did the tumor show? A. nuclear atypia and comedonecrosis B. reactive lymphocytes C. invasive ductal carcinoma D. signs of metastasis
A. nuclear atypia and comedonecrosis
TCGA-D8-A143-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A143-01Z-00-DX1.4697FB2F-91D5-4506-AF23-7DE304D44A3F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A143-01Z-00-DX1.4697FB2F-91D5-4506-AF23-7DE304D44A3F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A143-01Z-00-DX1.4697FB2F-91D5-4506-AF23-7DE304D44A3F_1_1024.npy
what is the final diagnosis? A. invasive ductal carcinoma in the left breast B. metastatic carcinoma C. reactive lymphocytes in the inner lower quadrant of the left breast D. invasive ductal carcinoma in situ in the left breast
D. invasive ductal carcinoma in situ in the left breast
TCGA-D8-A143-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A143-01Z-00-DX1.4697FB2F-91D5-4506-AF23-7DE304D44A3F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A143-01Z-00-DX1.4697FB2F-91D5-4506-AF23-7DE304D44A3F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A143-01Z-00-DX1.4697FB2F-91D5-4506-AF23-7DE304D44A3F_1_1024.npy
what information is included in the patient's general profile? A. date of birth, height, weight, and marital status. B. chief complaints and symptoms. C. clinical findings. D. current medications and past medical history.
A. date of birth, height, weight, and marital status.
TCGA-C8-A273-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_1024.npy
what specific information is provided in the patient's history? A. ob/gyn history. B. smoking history. C. hiv/hepatitis status. D. clinical diagnosis.
B. smoking history.
TCGA-C8-A273-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_1024.npy
what is the purpose of the biopsy in this case? A. to collect cancerous tissue for research purposes. B. to diagnose the patient's condition. C. to determine the patient's hiv/hepatitis status. D. to collect general patient information.
A. to collect cancerous tissue for research purposes.
TCGA-C8-A273-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_1024.npy
what information is provided in the clinical findings? A. date of birth, height, weight, and marital status. B. chief complaints and symptoms. C. current medications and past medical history. D. details about the patient's current condition.
D. details about the patient's current condition.
TCGA-C8-A273-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_1024.npy
who provides comments at the end of the slide? A. the patient. B. the director of research pathology. C. the patient's doctor. D. the director of the research facility.
B. the director of research pathology.
TCGA-C8-A273-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_1024.npy
what is the final section of the slide? A. general patient information. B. clinical diagnosis. C. histological diagnosis. D. chief complaints and symptoms.
C. histological diagnosis.
TCGA-C8-A273-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5_1_1024.npy
what is the nuclear grade of the ductal carcinoma in situ (dcis)? A. grade 1 B. grade 2 C. grade 3 D. not mentioned
A. grade 1
TCGA-BH-A0DT-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0DT-01Z-00-DX1.73AFCEBB-06B1-4870-ADA2-881511B1BE2D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0DT-01Z-00-DX1.73AFCEBB-06B1-4870-ADA2-881511B1BE2D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0DT-01Z-00-DX1.73AFCEBB-06B1-4870-ADA2-881511B1BE2D_1_1024.npy